Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot - Wikidata - wikimedia - TriplyDB

Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot

Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot

http://www.wikidata.org/entity/Q33602274

about

The Charcot foot in diabetes The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy Charcot osteoarthropathy in type 2 diabetes persons presenting to specialist diabetes clinic at a tertiary care hospital Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy.Offloading treatment is linked to activation of proinflammatory cytokines and start of bone repair and remodeling in Charcot arthropathy patients.Impact of Charcot neuroarthropathy on metatarsal bone mineral density and geometric strength indices Endophenotype Network Models: Common Core of Complex Diseases.An overview of the Charcot foot pathophysiology.Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature.The pathogenesis of Charcot neuroarthropathy: current concepts.Medical management of Charcot arthropathy.Charcot foot syndrome.Neuropathic osteoarthropathy with and without superimposed osteomyelitis in patients with a diabetic foot.Pathogenesis and potential relative risk factors of diabetic neuropathic osteoarthropathy.Immunosuppression therapy posttransplantation can be associated with a different clinical phenotype for diabetic charcot foot neuroarthropathy.Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment.Novel use of a Dektak 150 surface profiler unmasks differences in resorption pit profiles between control and Charcot patient osteoclasts.Diabetic Neuropathy and Gait: A Review.Audit of acute Charcot's disease in the UK: the CDUK study.Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction.Neuroarthropathy in diabetes: pathogenesis of Charcot arthropathy.Ligation of Na, K ATPase β3 subunit on monocytes by a specific monoclonal antibody mediates T cell hypofunction.Risk factors for Charcot foot Markers of Local Inflammation and Bone Resorption in the Acute Diabetic Charcot Foot

P2860

Q24612582-DAAB9F7A-6DFF-4F66-9D13-788B3C0A76FB Q35123561-8C8BA6C1-F857-434B-AD48-FABBBAC430D3 Q35660995-27EBD648-10F9-413B-8245-D9D55748FB1B Q35744929-45A7BD12-6E97-4EDF-BE7B-D4F15D47EAD7 Q36364298-4B3A88F5-77EE-4EC0-8ABE-B27B2EE91375 Q36448794-91532DBB-0C02-4D61-B88E-FF86BC4F48D6 Q36985809-E9BED121-7557-4AE8-871A-0584693A04AB Q37068742-22705B6B-296A-4E24-AAF9-4DA9B02CCEE3 Q37585982-00658789-51F3-4B50-BD4A-99D6D7CD0DC1 Q37987820-A822D4F1-4C08-4146-A540-BE5547A0D40B Q37991311-265D73C2-680F-4A41-8F3F-4A1B131F41A3 Q38031994-EF1D591F-37DD-40BD-940B-9933C2BDE0BB Q38394379-EFFD4090-6BF4-4816-8F75-607A679E84C2 Q38736311-0A41023D-78C6-4F58-9466-16A720F0BCF9 Q42284515-8140BA14-FA5D-4D38-B26A-CE1136CA44B7 Q42837821-4BD9C19B-A018-4097-9963-E9C961CB34C3 Q45018573-FFB27D74-3BA8-4410-88C3-C7FAC0555681 Q45253652-BD3E4542-9847-4EE1-B4A6-6BF9FCB730EE Q45893874-00E2F176-E1BC-414F-AF6D-D9DC67953B7F Q46601681-B90FCCDB-78EC-4869-9B3A-027A425FE5F9 Q47139699-4C3A4068-1823-40EA-8DC7-57E5D1E3E291 Q55280458-D0368304-43A8-436B-BBB7-82980A979D3E Q55449230-B2B0A4F9-C10E-4FFE-B8C7-C94F6067D5DF Q56797827-47A8075B-B332-4492-B21B-7779C8B69E9A Q58803025-F9E5000E-808E-4499-9727-31521F876C1B

P2860

Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot

http://www.wikidata.org/entity/Q33602274

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Proinflammatory modulation of ...... tients with acute Charcot foot

@ast

Proinflammatory modulation of ...... tients with acute Charcot foot

@en

type

label

Proinflammatory modulation of ...... tients with acute Charcot foot

@ast

Proinflammatory modulation of ...... tients with acute Charcot foot

@en

prefLabel

Proinflammatory modulation of ...... tients with acute Charcot foot

@ast

Proinflammatory modulation of ...... tients with acute Charcot foot

@en

P1433

Q33602274-69A55E27-47AF-4A5B-918B-BD35EF84201F

P1476

Q33602274-9C89E65D-EE53-4008-9BD1-ADC97C2C810F

P2093

Q33602274-03319F97-236D-4FAC-A40A-57082A8D60B8

Q33602274-128CE0CB-91A1-4831-80CC-1D2F743721D3

Q33602274-31E3152A-BC5B-4C8E-9825-403FC18D5C14

Q33602274-4EE3E3E5-1F9D-40C3-B367-BD72C6874ABD

Q33602274-52303BF6-3967-4205-BFC1-D3A89BB01C90

Q33602274-6170B42B-68A6-44EB-8CF9-01A97B5783C5

Q33602274-BA9734F5-B0C4-42C4-AED7-42BB45AED8D8

Q33602274-BFC9304C-DA7A-4329-91D8-73DD640D3D72

Q33602274-C789F418-8D2C-4F81-B641-31CB66343FE7

Q33602274-D58E4C2F-BB10-4DD2-8733-E2078EF0B23E

P2860

Q33602274-247706DD-086F-49E4-B884-8D0721BEBECD

Q33602274-722EB1CB-C26A-4F32-A734-4FBE24BB2979

Q33602274-73EE0E0C-E616-40CA-B48F-0B1E48E097A4

Q33602274-74D57E9E-2E6D-4FC7-8C7D-164FE2D5D09A

Q33602274-74F0E4E7-9CA9-4748-B4FB-BE64DFB66CC0

Q33602274-75657B49-4C7F-49C3-8575-C45FBD932873

Q33602274-792DC270-322A-4EC1-8BBD-701A7C48C224

Q33602274-7AF425D2-46F4-43DB-B7CB-0E13267D67F0

Q33602274-8ABF576F-5ED6-4522-9955-0E2A65973BEA

Q33602274-9D8EEB28-E216-4D26-9160-A7576E7A8716

P304

Q33602274-77BF9EEF-5781-462A-A11E-39E57D637098

P31

Q33602274-EE58F6B8-293C-4797-8D16-EE62618A288F

P356

Q33602274-5F39E0CE-1761-49DA-94A2-CD606572EBB2

P407

Q33602274-527141AC-5FB4-445F-82F3-F0C7EAD66F45

P433

Q33602274-0A6E9802-789D-498D-9D1F-DBF231DA2A6F

P478

Q33602274-C0A70097-9A14-4B3D-B59B-5DA27CD2A792

P50

Q33602274-4E89594F-52FE-4032-80E6-009953593779

P577

Q33602274-BF28A05D-BEBD-440B-BB77-E96E14252AC3

P5875

Q33602274-340F3F58-3BA1-4FCC-BCE9-16CBF3DE84AA

P698

Q33602274-EBBCAD6F-B25D-433D-9227-FDA3994F58D2

P932

Q33602274-607A8286-EC09-43E2-9856-8C57765AA712

P356

P1433

P1476

Proinflammatory modulation of ...... tients with acute Charcot foot

@en

P2093

Alberto Bergamini

http://www.w3.org/2001/XMLSchema#string

Anna Sinistro

http://www.w3.org/2001/XMLSchema#string

Chiara Ciaprini

http://www.w3.org/2001/XMLSchema#string

Cristiana Almerighi

http://www.w3.org/2001/XMLSchema#string

Erika Vainieri

http://www.w3.org/2001/XMLSchema#string

Francesca Spasaro

http://www.w3.org/2001/XMLSchema#string

Giovanni Rocchi

http://www.w3.org/2001/XMLSchema#string

Laura Giurato

http://www.w3.org/2001/XMLSchema#string

Luigi Uccioli

http://www.w3.org/2001/XMLSchema#string

Valeria Ruotolo

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Osteoclast differentiation and activation

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.

In vivo activation of antigen-specific CD4 T cells.

Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis

Calcitonin gene-related peptide: multiple actions, multiple receptors.

The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes.

P304

350-355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-1141

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Antonella Cavazza

P577

2009-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38058829

http://www.w3.org/2001/XMLSchema#string

P698

19880584

http://www.w3.org/2001/XMLSchema#string

P932

2809281

http://www.w3.org/2001/XMLSchema#string